You Lü

Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues

Guangping Gao, Luk H. Vandenberghe, Mauricio R. Alvira et al. · Journal of Virology · 2004 · 1K citations · Full text

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

You Lü, Jianxin Xue, Tao Deng et al. · Nature Medicine · 2020 · 510 citations

Off-target Effect, Medicine, Immunology +10

Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial

Jean‐Charles Soria, Yi‐Long Wu, Kazuhiko Nakagawa et al. · The Lancet Oncology · 2015 · 404 citations

Chemotherapy Versus Placebo, Medicine, First-line Gefitinib +9

BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer

Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · Journal of Clinical Oncology · 2015 · 381 citations · Full text

Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)

Yunpeng Yang, Zhehai Wang, Jian Fang et al. · Journal of Thoracic Oncology · 2020 · 376 citations · Full text